The Cancer Letter

Inside information on cancer research and drug development

Vol.
24
No.
5
May 25, 2001May 25, 2001
Free
DOWNLOAD THE PDF

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

Preoperative Chemo Doubles Survival In Locally Advanced Bladder Cancer

Gleevec Approval Sets Record For FDA Review: 73 Days

Advances Found In Treatment Of Aerodigestive Cancers

Silicone Implants Not Linked To Increased Risk Of Death

B-14 Trial: No Advantage To 10 Years Of Tamoxifen

NCI-Approved Clinical Trials Listed For April 2001

Can you spare 10 minutes to complete a survey?

Your feedback is really important—you're helping us shape our coverage priorities and services to better serve you, our readers.
COMPLETE OUR SURVEY

Login

Site license subscribers:
Log in with your IP | Register a sponsored account